In Vitro Susceptibility to Quinolones of Francisella tularensis subspecies tularensis
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 34 (5) , 327-330
- https://doi.org/10.1080/00365540110080773
Abstract
Francisella tularensis is a potent pathogen and a possible bioterrorism agent, for which quinolones offer promising new therapeutic options. There are, however, no data on the susceptibility to quinolones of natural isolates of F. tularensis tularensis, the highly virulent North American subspecies. In the present study, 8 isolates of F. tularensis tularensis, originating from 8 different states of the USA, and 16 US isolates of F. tularensis holarctica were tested. All 24 isolates showed MIC values ≤⃒ 0.125 mg/l to 6 different quinolones. Against ciprofloxacin, the predominant quinolone used to date in therapy against subspecies holarctica, MIC values were consistently ≤⃒ 0.064 mg/l. Thus quinolones seem to be promising options for the treatment of tularemia, including cases caused by the highly virulent subspecies F. tularensis tularensis.Keywords
This publication has 11 references indexed in Scilit:
- An Outbreak of Primary Pneumonic Tularemia on Martha's VineyardNew England Journal of Medicine, 2001
- Tularemia Epidemic in Northwestern Spain: Clinical Description and Therapeutic ResponseClinical Infectious Diseases, 2001
- Ciprofloxacin for Treatment of TularemiaClinical Infectious Diseases, 2001
- Tularemia as a Biological WeaponJAMA, 2001
- In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animalsJournal of Antimicrobial Chemotherapy, 2000
- Ciprofloxacin for treatment of tularemia in childrenThe Pediatric Infectious Disease Journal, 2000
- Treatment of Tularemia with Fluoroquinolones: Two Cases and ReviewClinical Infectious Diseases, 1999
- Streptomycin and Alternative Agents for the Treatment of Tularemia: Review of the LiteratureClinical Infectious Diseases, 1994
- Susceptibility pattern of Scandinavian Francisella tularensis isolates with regard to oral and parenteral antimicrobial agentsAPMIS, 1993
- TULAREMIC PNEUMONIAThe Lancet Healthy Longevity, 1945